Navigation Links
Complete Genomics and Illumina Settle Patent Litigation
Date:7/18/2013

MOUNTAIN VIEW, Calif., July 18, 2013 /PRNewswire/ -- Complete Genomics, Inc. (formerly NASDAQ: GNOM) ("Complete"), a wholly-owned subsidiary of BGI-Shenzhen ("BGI"), a leading international genomics organization based in Shenzhen, China, today announced that it has entered into a settlement agreement with Illumina, Inc. under which Illumina will dismiss with prejudice both lawsuits it had brought against Complete:  Illumina, Inc. and Solexa, Inc. v. Complete Genomics, Inc., Case No. 10-cv-05542 EDL (N.D. Cal.); and Illumina, Inc. and Illumina Cambridge Ltd. v. Complete Genomics, Inc., Case No. 12-cv-01465 BEN BGS (S.D. Cal).  Complete will dismiss with prejudice all counterclaims.  The parties have entered into mutual releases, and each party will bear its own litigation costs.  No payment is being made by either party to the other, and no licenses are being granted by either party to the other.

"We are pleased to have reached a settlement with Illumina regarding this matter.  This resolution allows Complete to focus on its vision of revolutionizing medicine through the use of whole genome sequencing," Dr. Clifford Reid, CEO of Complete, said.

About Complete

Complete Genomics provides the most accurate whole human genome sequencing available today. The company's proprietary sequencing technology and advanced informatics and analysis software provide researchers and clinicians worldwide with the genomic information needed to better understand the prevention, diagnosis, and treatment of diseases. Additional information can be found at http://www.completegenomics.com.


'/>"/>
SOURCE Complete Genomics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Complete Titrator Systems from Cole-Parmer Offer Easy-To-Use Apps-Based Interface
2. Replicel and Shiseido Complete Collaboration and Technology Transfer Agreement on Technology for Treating Pattern Baldness
3. Eurofins MWG Operon Quality Assurance Group Completes ISO Certifications for Their New Overnight Sequencing Lab
4. Oligomerix, Inc. Completes Series B Financing
5. Leviticus Cardio Ltd. Completes a Successful Animal Trial for its Wireless Energy System for VADs
6. St. Mary Completes Phase 2 of Its Emergency Department and Trauma Center Expansion
7. Centene Corporation Completes Acquisition Of Specialty Pharmacy Leader AcariaHealth
8. bioRASI Completes Acquisition of Ukrainian CRO
9. Novira Therapeutics Completes $25 Million Series A Financing
10. SoundMindz TM Releases ‘Anti-Anxiety TM’ Mobile App - A Complete Stress Therapy Program
11. BGI-Shenzhen Completes Acquisition of Complete Genomics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2017)... Oct. 9, 2017  BioTech Holdings announced today ... which its ProCell stem cell therapy prevents limb ... The Company, demonstrated that treatment with ProCell resulted ... saved as compared to standard bone marrow stem ... resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... ... October 09, 2017 , ... The Giving ... marijuana products targeting the needs of consumers who are incorporating medical marijuana into ... in Phoenix, Arizona. , As operators of two successful Valley dispensaries, The Giving ...
(Date:10/7/2017)... (PRWEB) , ... October 06, ... ... leader in Hi-C-based genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, ... Hi-C kit and accompanying cloud-based bioinformatics software to perform Hi-C metagenome deconvolution ...
(Date:10/6/2017)... ... October 06, 2017 , ... On Tuesday, October 24th, ABC² ... the first-ever adaptive clinical trial for glioblastoma (GBM). The featured speaker will be ... and open to the public, but registration is required. , WHAT: ABC² ...
Breaking Biology Technology:
(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)... 2017 Trends, opportunities and forecast in this ... technology (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, ... end use industry (government and law enforcement, commercial and ... and others), and by region ( North America ... Asia Pacific , and the Rest of the ...
Breaking Biology News(10 mins):